Evidence map›Paper›PMID 22405256›Full record

ArticleBMC complementary and alternative medicine2012

Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells.

Sutapa Mahata, Saurabh Maru, Shirish Shukla, Arvind Pandey, G Mugesh, Bhudev C Das, Alok C Bharti

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Perceived Changes in Anxiety Symptom Burden During Treatment withPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sutapa MahataDivision of Molecular Oncology, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida 201301, India.
Saurabh Maru
Shirish Shukla
Arvind Pandey
G Mugesh
Bhudev C Das
Alok C Bharti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBryophyllum pinnata (B. pinnata) is a common medicinal plant used in traditional medicine of India and of other countries for curing various infections, bowel diseases, healing wounds and other ailments. However, its anticancer properties are poorly defined. In view of broad spectrum therapeutic potential of B. pinnata we designed a study to examine anti-cancer and anti-Human Papillomavirus (HPV) activities in its leaf extracts and tried to isolate its active principle.

methodsA chloroform extract derived from a bulk of botanically well-characterized pulverized B. pinnata leaves was separated using column chromatography with step- gradient of petroleum ether and ethyl acetate. Fractions were characterized for phyto-chemical compounds by TLC, HPTLC and NMR and Biological activity of the fractions were examined by MTT-based cell viability assay, Electrophoretic Mobility Shift Assay, Northern blotting and assay of apoptosis related proteins by immunoblotting in human cervical cancer cells.

resultsResults showed presence of growth inhibitory activity in the crude leaf extracts with IC50 at 552 μg/ml which resolved to fraction F4 (Petroleum Ether: Ethyl Acetate:: 50:50) and showed IC50 at 91 μg/ml. Investigations of anti-viral activity of the extract and its fraction revealed a specific anti-HPV activity on cervical cancer cells as evidenced by downregulation of constitutively active AP1 specific DNA binding activity and suppression of oncogenic c-Fos and c-Jun expression which was accompanied by inhibition of HPV18 transcription. In addition to inhibiting growth, fraction F4 strongly induced apoptosis as evidenced by an increased expression of the pro-apoptotic protein Bax, suppression of the anti-apoptotic molecules Bcl-2, and activation of caspase-3 and cleavage of PARP-1. Phytochemical analysis of fraction F4 by HPTLC and NMR indicated presence of activity that resembled Bryophyllin A.

conclusionsOur study therefore demonstrates presence of anticancer and anti-HPV an activity in B. pinnata leaves that can be further exploited as a potential anticancer, anti-HPV therapeutic for treatment of HPV infection and cervical cancer.

Indexed as

PhytotherapyAntineoplastic Agents, PhytogenicAntiviral AgentsApoptosisbcl-2-Associated X ProteinBufanolidesCaspase 3Cell Line, TumorCell ProliferationDown-RegulationFemaleHumansInhibitory Concentration 50KalanchoePapillomaviridaePapillomavirus InfectionsAntineoplastic Agents, PhytogenicAntiviral Agentsbcl-2-Associated X Proteinbryophyllin ABufanolidesCaspase 3Plant ExtractsPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junTranscription Factor AP-1

Identifiers

PMID22405256
PMCPMC3353166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.